Mocetinostat Completed Phase 2 Trials for Metastatic Leiomyosarcoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02303262SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma